
|Articles|April 24, 2008
Vyvanse approved to treat adults with ADHD
Shire plc's Vyvanse can now be treated not only among children but also adults.
Advertisement
Approved in July 2007 to treat attention deficit hyperactivity disorder (ADHD) in kids six to 12 years of age, Shire plc's
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: The Initiative Bringing Clinical Pharmacy Care to Underserved Patients’ Homes
2
Pharmacists Reimagine the Future of Pharmacy
3
Investigators Link Maternal Distress With Neurodevelopmental Delay Among Children
4
Pharmacists Discuss Innovation Strategies at NCPA 2025
5




















































































































































